Heartland Advisors Inc. raised its holdings in Core Laboratories Inc. (NYSE:CLB – Free Report) by 5.8% in the third quarter, Holdings Channel.com reports. The fund owned 1,119,900 shares of the oil and gas company’s stock after buying an additional 61,589 shares during the quarter. Heartland Advisors Inc.’s holdings in Core Laboratories were worth $10,863,000 at the end of the most recent reporting period.
Several other institutional investors also recently made changes to their positions in CLB. State of Wyoming increased its holdings in shares of Core Laboratories by 267.7% in the 1st quarter. State of Wyoming now owns 4,626 shares of the oil and gas company’s stock valued at $78,000 after purchasing an additional 3,368 shares in the last quarter. Voya Investment Management LLC acquired a new stake in shares of Core Laboratories in the third quarter valued at about $98,000. Fifth Third Bancorp lifted its stake in shares of Core Laboratories by 2,397.6% in the first quarter. Fifth Third Bancorp now owns 11,414 shares of the oil and gas company’s stock valued at $192,000 after purchasing an additional 10,957 shares during the period. Corient Private Wealth LP purchased a new stake in Core Laboratories during the second quarter worth about $141,000. Finally, The Manufacturers Life Insurance Company purchased a new stake in Core Laboratories during the second quarter worth about $156,000. 97.81% of the stock is currently owned by hedge funds and other institutional investors.
Core Laboratories Trading Up 0.7%
NYSE:CLB opened at $8.45 on Thursday. Core Laboratories Inc. has a 52-week low of $8.12 and a 52-week high of $20.36. The company has a quick ratio of 1.60, a current ratio of 2.19 and a debt-to-equity ratio of 0.40. The stock has a fifty day simple moving average of $10.13 and a 200-day simple moving average of $13.25. The company has a market capitalization of $386.95 million, a PE ratio of 22.22, a price-to-earnings-growth ratio of 1.67 and a beta of 1.18.
Core Laboratories (NYSE:CLB – Get Free Report) last issued its quarterly earnings data on Wednesday, October 28th. The oil and gas company reported $0.16 EPS for the quarter, meeting analysts’ consensus estimates of $0.16. Core Laboratories had a net margin of 3.42% and a return on equity of 8.94%. The firm had revenue of $132.08 million for the quarter, compared to analysts’ expectations of $131.87 million. During the same period in the prior year, the company earned $0.22 EPS. The firm’s revenue was down 1.8% on a year-over-year basis. On average, equities research analysts expect that Core Laboratories Inc. will post 0.56 earnings per share for the current fiscal year.
Core Laboratories Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Stockholders of record on Monday, November 9th will be given a $0.01 dividend. The ex-dividend date is Monday, November 9th. This represents a $0.04 annualized dividend and a dividend yield of 0.5%. Core Laboratories’s dividend payout ratio is currently 10.53%.
Analysts Set New Price Targets
Several research analysts have weighed in on the stock. Weiss Ratings lowered shares of Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, November 13th. Johnson Rice upgraded shares of Core Laboratories from a “hold” rating to a “buy” rating and set a $21.00 price target for the company in a research report on Thursday, August 13th. Finally, Wall Street Zen raised Core Laboratories from a “sell” rating to a “hold” rating in a research note on Saturday, August 1st. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, Core Laboratories currently has a consensus rating of “Hold” and an average price target of $21.00.
Get Our Latest Research Report on CLB
Core Laboratories Company Profile
Core Laboratories Inc. provides specialized services and products to the oil and natural gas industry. Its work helps customers evaluate reservoirs and improve the performance of producing wells. The company’s Reservoir Description business analyzes rock and fluid samples and provides laboratory testing, data, and reservoir studies. These services help energy companies assess subsurface properties and make decisions about exploration and field development. Through its Production Enhancement business, Core Laboratories offers well diagnostics, completion-related services, and technologies designed to support production and improve recovery.
Recommended Stories
- Five stocks we like better than Core Laboratories
- Grounded at 52-Week Lows: When Will Boeing Stock Take Flight?
- Apple’s Next Margin Defense Could Be Hiding in Your Wallet
- From Berlin to Brussels: Tesla’s $3.3 Billion Robotaxi Gamble
- Target Stock Is Up Over 70%—Has the Easy Money Already Been Made?
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories Inc. (NYSE:CLB – Free Report).
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
